IRD
Opus Genetics, Inc.
5.10$
+6.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | 0.00 | 0.04 | 1.93 | 0.88 | 0.41 | 0.02 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | 0.00 | 0.04 | 1.93 | 0.88 | 0.41 | 0.02 | |
| 0.33 | 1.43 | 1.02 | 0.70 | 0.82 | 1.01 | 0.05 | |
| 0.26 | 0.60 | 0.55 | 0.35 | 0.55 | 0.68 | 0.04 | |
| 0.59 | 4.28 | 1.57 | 1.05 | 1.37 | 2.73 | 0.08 | |
| -0.59 | -4.28 | -1.53 | 0.88 | -0.49 | -2.32 | -0.06 | |
| 0.20 | 1.47 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | |
| -0.87 | -5.28 | -3.82 | 0.88 | -0.46 | -2.15 | -0.08 | |
| – | – | – | 0.02 | 0.00 | – | – | |
| -0.87 | -5.28 | -3.82 | 0.87 | -0.46 | -2.15 | -0.08 | |
| -0.67 | -3.81 | -3.82 | 0.88 | -0.46 | -2.15 | -0.08 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.